Editor: Atta-ur-Rahman, FRS

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 6

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-340-7 (Print)
ISBN: 978-1-68108-339-1 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810833911170601

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders is a book series concerned with Alzheimer's disease (AD) that causes dementia, or loss of brain function. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s disease research.

The sixth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:

  • - treatment of brain inflammation in Alzheimer’s disease with traditional medicine
  • - stem cell strategies for the modeling and therapy of Alzheimer’s disease
  • - retinal neurodegeneration in Alzheimer’s disease
  • - biological mass spectrometry for diagnosis of Alzheimer's disease

…and more.

Preface

- Pp. I
Atta -ur-Rahman
Download Free

List of Contributors

- Pp. II
Atta-ur-Rahman
Download Free

The Treatment of Brain Inflammation in Alzheimer’s Disease. Can Traditional Medicines Help?

- Pp. 1-19 (19)
James David Adams
View Abstract

Stem Cell Strategies for the Modeling and Therapy of Alzheimer’s Disease

- Pp. 20-55 (36)
Haigang Gu
View Abstract

Retinal Neurodegeneration in Alzheimer’s Disease

- Pp. 56-86 (31)
L. Guo, M. Pahlitzsch, F. Javaid, M. F. Cordeiro
View Abstract

Pathophysiology of Alzheimer Disease: Current Drug Therapy

- Pp. 87-109 (23)
Sumeet Gupta, Vikas Jhawat
View Abstract

Biological Mass Spectrometry for Diagnosis of Alzheimer's Disease

- Pp. 110-126 (17)
Hani Nasser Abdelhamid, Hui-Fen Wu
View Abstract

The Structure-Activity Relationship of Melanin as a Source of Energy Defines the Role of Glucose to Biomass Supply Only, Implications in the Context of the Failing Brain

- Pp. 127-153 (27)
Arturo Solís Herrera
View Abstract

Neuro-protective Properties of the Fungus Isaria japonica: Evidence from a Mouse Model of Agedrelated Degeneration

- Pp. 154-186 (33)
Koichi Suzuki, Masaaki Tsushima, Masanobu Goryo, Tetsuro Shinada, Yoko Yasuno, Eiji Nishimura, Yasuo Terayama, Yuki Mori, Yoshichika Yoshioka
View Abstract

Subject Index

- Pp. 187-196 (10)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Animal Models for Neurological Disorders.
.Frontiers in Clinical Drug Research – Dementia.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.